Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Asset disposition
Translate Bio, Inc. (TBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/14/2021 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Third Restated Certificate of Incorporation of Translate Bio",
"Second Amended and Restated Bylaws of Translate Bio"
08/03/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Agreement and Plan of Merger, by and among Sanofi, Vector Merger Sub, Inc. and Translate Bio, Inc",
"Tender and Support Agreement by and between Sanofi and Baupost Group Securities, L.L.C.",
"Tender and Support Agreement by and between Sanofi and Ronald C. Renaud, Jr.",
"Sanofi to Acquire Translate Bio; Advances Deployment of mRNA Technology across Vaccines and Therapeutics Development"
06/16/2021 8-K Quarterly results
04/20/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
12/28/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
12/22/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/25/2020 8-K Quarterly results
07/20/2020 8-K Quarterly results
06/26/2020 8-K Quarterly results
06/23/2020 8-K Quarterly results
06/16/2020 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 16, 2020 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable"
04/07/2020 8-K Other Events
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable"
03/27/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 26, 2020 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable",
"Sanofi Pasteur and Translate Bio to collaborate to develop a novel mRNA vaccine candidate against COVID-19"
03/26/2020 8-K Quarterly results
01/13/2020 8-K Investor presentation
Docs: "Corporate slide presentation of Translate Bio, Inc."
12/12/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : December 11, 2019 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable",
"Translate Bio Announces Executive Leadership Appointments"
09/18/2019 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 17, 2019 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable",
"Underwriting Agreement, by and among the Company and Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC",
"Opinion of Wilmer Cutler Pickering Hale and Dorr LLP",
"Translate Bio Announces Pricing of Public Offering of Common Stock"
09/12/2019 8-K Quarterly results
07/31/2019 8-K Quarterly results
07/15/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 12, 2019 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable"
06/19/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 18, 2019 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable"
05/01/2019 8-K Quarterly results
04/11/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
04/08/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : April 3, 2019 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable"
01/03/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "FORM 8-K"
07/09/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 9, 2018 Translate Bio, Inc. Delaware 001-38550 61-1807780 29 Hartwell Avenue Lexington, Massachusetts 02421 Registrant's telephone number, including area code: 945-7361 Not applicable",
"Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases"
07/02/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Restated Certificate of Incorporation of Translate Bio, Inc",
"Amended and Restated Bylaws of Translate Bio, Inc"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy